NCT03702907 DC Longitudinal Study on Aging and Specimen Bank
| NCT ID | NCT03702907 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Georgetown University |
| Condition | Alzheimer Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2007-01-01 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2007-01-01 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Georgetown University Memory Disorders Program, part of the Department of Neurology, is conducting pilot studies of the feasibility of various diagnostic tests for Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. Further, this study is assessing longitudinal changes in biological, lifestyle, and cognitive assessment collection. The primary goal of this study is to examine the feasibility of biochemical assays, genetic testing, and cognitive and lifestyle assessments in the ante-mortem diagnosis of Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. This research involves genetic and cognitive status testing but the findings will not be shared with research subjects. This will be accomplished ex vivo using blood, and/or cerebrospinal fluid (CSF) specimens from patients with a diagnosis of probable Alzheimer's disease, mild cognitive impairment, or other neurodegenerative diseases and from normal controls.
Eligibility Criteria
Inclusion Criteria: * Age 45 and older. * Subjects within the age range of 45-50 years old must have a first degree relative with a neurodegenerative disease. Exclusion Criteria: * Individuals under 45 years of age
Frequently Asked Questions
Who can join the NCT03702907 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, studying Alzheimer Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03702907 currently recruiting?
Yes, NCT03702907 is actively recruiting participants. Visit ClinicalTrials.gov or contact Georgetown University to inquire about joining.
Where is the NCT03702907 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT03702907 clinical trial?
NCT03702907 is sponsored by Georgetown University. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.